Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             119 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers Chik, Zamri
2010
32 Supplement 3 p. 1822-1831
10 p.
artikel
2 A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials Zhao, Sihai
2010
32 Supplement 3 p. 1565-1577
13 p.
artikel
3 Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: Subpopulation analysis of a prospective, open-label extension study of up to 48 weeks Piña-Garza, Jesus Eric
2010
32 Supplement 3 p. 1935-1950
16 p.
artikel
4 A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective Nuijten, Mark
2010
32 Supplement 3 p. 717-728
12 p.
artikel
5 A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type Nikfar, Shekoufeh
2010
32 Supplement 3 p. 1871-1888
18 p.
artikel
6 An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers Tomkinson, Helen K.
2010
32 Supplement 3 p. 1372-1386
15 p.
artikel
7 A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses Beran, Jiri
2010
32 Supplement 3 p. 2186-2197
12 p.
artikel
8 A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients Kuypers, Dirk R.J.
2010
32 Supplement 3 p. 2012-2023
12 p.
artikel
9 A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Repeat-Dose Study of Two Intravenous Acetaminophen Dosing Regimens for the Treatment of Pain After Abdominal Laparoscopic Surgery Wininger, Steven J.
2010
32 Supplement 3 p. 2348-2369
22 p.
artikel
10 A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005 Hansen, Richard A.
2010
32 Supplement 3 p. 1308-1319
12 p.
artikel
11 A retrospective, observational cohort analysis of a nationwide database to compare heart failure prescriptions and related health care utilization before and after publication of updated treatment guidelines in the United States Shafazand, Shirin
2010
32 Supplement 3 p. 1642-1650
9 p.
artikel
12 A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers Salem, Isam I.
2010
32 Supplement 3 p. 391-395
5 p.
artikel
13 A review of the treatment of chronic hepatitis C virus infection in cirrhosis Vezali, Elena
2010
32 Supplement 3 p. 2117-2138
22 p.
artikel
14 A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: A multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study Mehlisch, Donald R.
2010
32 Supplement 3 p. 1033-1049
17 p.
artikel
15 Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers Stockis, Armel
2010
32 Supplement 3 p. 1813-1821
9 p.
artikel
16 Besifloxacin: A topical fluoroquinolone for the treatment of bacterial conjunctivitis Chang, Mei H.
2010
32 Supplement 3 p. 454-471
18 p.
artikel
17 Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, two-way crossover study Zhang, Qian
2010
32 Supplement 3 p. 171-178
8 p.
artikel
18 Bioequivalence and pharmacokinetic evaluation of two formulations of glimepiride 2 mg: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy chinese male volunteers Liu, Yun
2010
32 Supplement 3 p. 986-995
10 p.
artikel
19 Bioequivalence of two tablet formulations of clopidogrel in healthy argentinian volunteers: A single-dose, randomized-sequence, open-label crossover study Di Girolamo, Guillermo
2010
32 Supplement 3 p. 161-170
10 p.
artikel
20 Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase Gordon, Allan
2010
32 Supplement 3 p. 844-860
17 p.
artikel
21 Changes in the QTc interval after administration of flecainide acetate, with and without coadministered Paroxetine, in Relation to Cytochrome P450 2D6 Genotype: Data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects Lim, Kyoung Soo
2010
32 Supplement 3 p. 659-666
8 p.
artikel
22 Clevidipine for the treatment of severe hypertension in adults Nguyen, Huan M.
2010
32 Supplement 3 p. 11-23
13 p.
artikel
23 Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review Chiappini, Elena
2010
32 Supplement 3 p. 66-88
23 p.
artikel
24 Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniae Marian Ijzerman, M.
2010
32 Supplement 3 p. 2198-2206
9 p.
artikel
25 Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers Ahmad, Mahmood
2010
32 Supplement 3 p. 607-613
7 p.
artikel
26 Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study Crank, Christopher W.
2010
32 Supplement 3 p. 1713-1719
7 p.
artikel
27 Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: A randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-center, modified factorial study Mehlisch, Donald R.
2010
32 Supplement 3 p. 882-895
14 p.
artikel
28 Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis Stankovic, Ivan
2010
32 Supplement 3 p. 909-914
6 p.
artikel
29 Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain Kwong, W. Jacqueline
2010
32 Supplement 3 p. 1768-1781
14 p.
artikel
30 Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands Westra, Tjalke A.
2010
32 Supplement 3 p. 1479-1495
17 p.
artikel
31 Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system Neubauer, Aljoscha S.
2010
32 Supplement 3 p. 1343-1356
14 p.
artikel
32 Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the united states during an influenza pandemic Dhankhar, Praveen
2010
32 Supplement 3 p. 1501-1516
16 p.
artikel
33 Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads Hey-Hadavi, Judith
2010
32 Supplement 3 p. 2036-2047
12 p.
artikel
34 Economic Analysis of Decitabine Versus Best Supportive Care in the Treatment of Intermediate- and High-Risk Myelodysplastic Syndromes From a US Payer Perspective Pan, Feng
2010
32 Supplement 3 p. 2444-2456
13 p.
artikel
35 Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: Meta-analysis of prospective studies Zanini, Barbara
2010
32 Supplement 3 p. 2139-2159
21 p.
artikel
36 Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study Farlow, Martin R.
2010
32 Supplement 3 p. 1234-1251
18 p.
artikel
37 Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study Marberger, Michael
2010
32 Supplement 3 p. 744-757
14 p.
artikel
38 Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study Vaz-da-Silva, Manuel
2010
32 Supplement 3 p. 179-192
14 p.
artikel
39 Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials Wortmann, Robert L.
2010
32 Supplement 3 p. 2386-2397
12 p.
artikel
40 Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in japanese patients with essential hypertension: Additional results from the REZALT study Shimada, Kazuyuki
2010
32 Supplement 3 p. 861-881
21 p.
artikel
41 Effects of glatiramer acetate on spasticity in previously interferon-β-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: A prospective, nonrandomized, open-label, uncontrolled, observational pilot study Meca-Lallana, José Eustasio
2010
32 Supplement 3 p. 1061-1066
6 p.
artikel
42 Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: An open-label, multiple-dose, controlled Phase I study in adults Schöller-Gyüre, Monika
2010
32 Supplement 3 p. 328-337
10 p.
artikel
43 Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: A retrospective chart review in Japanese patients Ishii, Hideki
2010
32 Supplement 3 p. 24-33
10 p.
artikel
44 Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: A meta-analysis of controlled clinical trials Alavian, Seyed-Moayed
2010
32 Supplement 3 p. 1-10
10 p.
artikel
45 Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study Rizos, Christos V.
2010
32 Supplement 3 p. 492-505
14 p.
artikel
46 Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: A systematic literature review van Riet-Nales, Diana A.
2010
32 Supplement 3 p. 924-938
15 p.
artikel
47 Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: A randomized, double-blind, parallel-group, placebo-controlled, multicenter study Higashi, Yoshinobu
2010
32 Supplement 3 p. 34-43
10 p.
artikel
48 Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: A multicenter, prospective, randomized, double-blind, double-dummy clinical trial Kim, Sang-Hyun
2010
32 Supplement 3 p. 1896-1905
10 p.
artikel
49 Efficacy of inhaled nitric oxide for hypoxic respiratory failure in term and late preterm infants by baseline severity of illness: A pooled analysis of three clinical trials Golombek, Sergio G.
2010
32 Supplement 3 p. 939-948
10 p.
artikel
50 Efficacy of Standard Doses of Ibuprofen Alone, Alternating, and Combined With Acetaminophen for the Treatment of Febrile Children Paul, Ian M.
2010
32 Supplement 3 p. 2433-2440
8 p.
artikel
51 Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis Kubiak, David W.
2010
32 Supplement 3 p. 637-648
12 p.
artikel
52 Fabry disease: From dermatologic entity to a treatable multi-organ disease Desnick, R.J.
2010
32 Supplement 3 p. S90-S92
3 p.
artikel
53 Immunological aspects of treatment of Pompe disease Kishnani, Priya S.
2010
32 Supplement 3 p. S49-S50
2 p.
artikel
54 Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study Tousoulis, Dimitris
2010
32 Supplement 3 p. 1720-1728
9 p.
artikel
55 Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: An open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers Kim, Bo-Hyung
2010
32 Supplement 3 p. 380-390
11 p.
artikel
56 Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: A noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patients Pfützner, Andreas
2010
32 Supplement 3 p. 1918-1934
17 p.
artikel
57 Irreversible encephalopathy after treatment with high-dose intravenous metronidazole Groothoff, Miriam V.R.
2010
32 Supplement 3 p. 60-64
5 p.
artikel
58 Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects Sarashina, Akiko
2010
32 Supplement 3 p. 1188-1204
17 p.
artikel
59 Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: Interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets Patrick, Donald L.
2010
32 Supplement 3 p. 275-292
18 p.
artikel
60 Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review Tol, Jolien
2010
32 Supplement 3 p. 437-453
17 p.
artikel
61 Nonadherence to oral linezolid after hospitalization: A retrospective claims analysis of the incidence and consequence of claim reversals Ball, Amy T.
2010
32 Supplement 3 p. 2246-2255
10 p.
artikel
62 [No title] Choi, Dong-Hyun
2010
32 Supplement 3 p. 399-
1 p.
artikel
63 Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study Arrieta, Antonio C.
2010
32 Supplement 3 p. 265-271
7 p.
artikel
64 Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily Haag, Sebastian
2010
32 Supplement 3 p. 678-690
13 p.
artikel
65 Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis Siniscalchi, Antonio
2010
32 Supplement 3 p. 2030-2034
5 p.
artikel
66 Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population Bollinger, Mary Elizabeth
2010
32 Supplement 3 p. 1093-1102
10 p.
artikel
67 Pharmacodynamic (Hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: Two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies Kim, Bo-Hyung
2010
32 Supplement 3 p. 193-205
13 p.
artikel
68 Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States Koomanachai, Pornpan
2010
32 Supplement 3 p. 766-779
14 p.
artikel
69 Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: A randomized, open-label, parallel-group, single- and multiple-dose study Jang, Seong Bok
2010
32 Supplement 3 p. 206-216
11 p.
artikel
70 Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males Liu, Yan-Mei
2010
32 Supplement 3 p. 1396-1407
12 p.
artikel
71 Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers Iqbal, Muzaffar
2010
32 Supplement 3 p. 588-596
9 p.
artikel
72 Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: A randomized, open-label, three-period crossover study in healthy volunteers Berges, Alienor
2010
32 Supplement 3 p. 1165-1177
13 p.
artikel
73 Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study Darwish, Mona
2010
32 Supplement 3 p. 2074-2087
14 p.
artikel
74 Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study Boellner, Samuel W.
2010
32 Supplement 3 p. 252-264
13 p.
artikel
75 Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: A randomized, open-label, ascending single- and multiple-dose study Li, Xue-Ning
2010
32 Supplement 3 p. 575-587
13 p.
artikel
76 Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-hodgkin's lymphoma or multiple myeloma Steinberg, Michael
2010
32 Supplement 3 p. 821-843
23 p.
artikel
77 Pompe disease: A clinical spectrum Deegan, Patrick
2010
32 Supplement 3 p. S46-S47
2 p.
artikel
78 Preconception Steroid Treatment in Infertile Women with Antithyroid Autoimmunity Undergoing Ovarian Stimulation and Intrauterine Insemination: A Double-Blind, Randomized, Prospective Cohort Study Turi, Angelo
2010
32 Supplement 3 p. 2415-2421
7 p.
artikel
79 Preference for formulations containing calcium and vitamin D3 in childhood: A randomized-sequence, open-label trial Bianchetti, Alessandra A.
2010
32 Supplement 3 p. 1083-1087
5 p.
artikel
80 Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9–10, 2009 Craig, Benjamin M.
2010
32 Supplement 3 p. 1546-1564
19 p.
artikel
81 Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: A prospective randomized study Koruk, Senem
2010
32 Supplement 3 p. 701-709
9 p.
artikel
82 Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial Miser, William F.
2010
32 Supplement 3 p. 896-908
13 p.
artikel
83 Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in australian patients: A cross-sectional, multicenter study Standfield, Lachlan
2010
32 Supplement 3 p. 1329-1342
14 p.
artikel
84 Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study Ullah, Md. Ashik
2010
32 Supplement 3 p. 1419-1426
8 p.
artikel
85 Relative bioavailability of generic and branded acetylcysteine effervescent tablets: A single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy chinese male volunteers Liu, Yan-Mei
2010
32 Supplement 3 p. 2097-2105
9 p.
artikel
86 Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: A randomized, open-label, crossover study in healthy adults Musson, Donald G.
2010
32 Supplement 3 p. 338-346
9 p.
artikel
87 Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states Homero de Souza Filho, José
2010
32 Supplement 3 p. 2088-2096
9 p.
artikel
88 Relative bioavailability of two oral formulations of piroxicam 20 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers Palma-Aguirre, Jose Antonio
2010
32 Supplement 3 p. 357-364
8 p.
artikel
89 Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers Belotto, Karisa Cristina Rodrigues
2010
32 Supplement 3 p. 2106-2115
10 p.
artikel
90 Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence Blais, Lucie
2010
32 Supplement 3 p. 1320-1328
9 p.
artikel
91 Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: A single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers Johnson, Franklin K.
2010
32 Supplement 3 p. 1149-1164
16 p.
artikel
92 Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States Lee, Won Chan
2010
32 Supplement 3 p. 1756-1767
12 p.
artikel
93 Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the Northern Netherlands between 2000 and 2006 Tu, Hong Anh T.
2010
32 Supplement 3 p. 133-144
12 p.
artikel
94 Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimens Meie, Giuseppe
2010
32 Supplement 3 p. 915-919
5 p.
artikel
95 Reversal of refractory sulfasalazine-related renal failure after treatment with corticosteroids Alivanis, Polichronis
2010
32 Supplement 3 p. 1906-1910
5 p.
artikel
96 Review of the efficacy and tolerability of the diclofenac epolamine topical patch 1.3% in patients with acute pain due to soft tissue injuries Kuehl, Kerry S.
2010
32 Supplement 3 p. 1001-1014
14 p.
artikel
97 Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study Arnold, Lesley M.
2010
32 Supplement 3 p. 1618-1632
15 p.
artikel
98 Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers Davis, John
2010
32 Supplement 3 p. 1889-1895
7 p.
artikel
99 Safety profile of abatacept in rheumatoid arthritis: A review Khraishi, Majed
2010
32 Supplement 3 p. 1855-1870
16 p.
artikel
100 Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: Cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands Boersma, Cornelis
2010
32 Supplement 3 p. 1103-1121
19 p.
artikel
101 Serious Early Childhood Wheezing After Respiratory Syncytial Virus Lower Respiratory Tract Illness in Preterm Infants Romero, José R.
2010
32 Supplement 3 p. 2422-2432
11 p.
artikel
102 Skin reaction and fever after treatment with pegvisomant in a patient with acromegaly Manavela, Marcos Paulo
2010
32 Supplement 3 p. 246-249
4 p.
artikel
103 Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing Stubenrauch, Kay
2010
32 Supplement 3 p. 1597-1609
13 p.
artikel
104 Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy Suzuki, Takaaki
2010
32 Supplement 3 p. 527-531
5 p.
artikel
105 Supplemental calcium in the chemoprevention of colorectal cancer: A systematic review and meta-analysis Carroll, Christopher
2010
32 Supplement 3 p. 789-803
15 p.
artikel
106 Systematic Review and Meta-Analysis of the Efficacy and Tolerability of Nicotine Preparations in Active Ulcerative Colitis Nikfar, Shekoufeh
2010
32 Supplement 3 p. 2304-2315
12 p.
artikel
107 Systematic reviews of assessment measures and pharmacologic treatments for agitation Zeller, Scott L.
2010
32 Supplement 3 p. 403-425
23 p.
artikel
108 The economic implications of treating atherothrombotic disease in australia, from the government perspective Ademi, Zanfina
2010
32 Supplement 3 p. 119-132
14 p.
artikel
109 The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: A cross-sectional study in Iran Namazi, Soha
2010
32 Supplement 3 p. 1050-1060
11 p.
artikel
110 The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study Li, Kun-Yan
2010
32 Supplement 3 p. 1674-1680
7 p.
artikel
111 Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China Zou, Li-Ping
2010
32 Supplement 3 p. 692-700
9 p.
artikel
112 Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study Martínková, Jirina
2010
32 Supplement 3 p. 2400-2414
15 p.
artikel
113 Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers Jung, Jinah
2010
32 Supplement 3 p. 1178-1187
10 p.
artikel
114 Tolerability and pharmacokinetics of TB-402 in healthy male volunteers Verhamme, Peter
2010
32 Supplement 3 p. 1205-1220
16 p.
artikel
115 Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: A descriptive report Donato, Bonnie M.K.
2010
32 Supplement 3 p. 546-554
9 p.
artikel
116 Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study Oparil, Suzanne
2010
32 Supplement 3 p. 1252-1269
18 p.
artikel
117 Unsuspected manifestations of Pompe disease: Focus on respiratory disturbances Confalonieri, Marco
2010
32 Supplement 3 p. S44-S45
2 p.
artikel
118 Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli Spangler, Mikayla L.
2010
32 Supplement 3 p. 53-56
4 p.
artikel
119 Willingness to pay for three hypothetical malaria vaccines in Nigeria Udezi, Waka Anthony
2010
32 Supplement 3 p. 1533-1544
12 p.
artikel
                             119 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland